Affiliation:
1. Middle Technical University, Medical Technical Institute –Baghdad
Abstract
The current work was done to determine the correlation between vitamin D and cystatin C as a predictor of kidney disease in males with diabetes mellitus. A total of 60 males were taken from October to December 2018. They were divided into 30 patients with type 2 diabetes and 30 healthy volunteers' as a control group. Glycated hemoglobin HbA1c, plasma glucose level, creatinine and urea were measured for all subjects. Also, levels of 25(OH) D and cystatin-c were determined using the enzyme-linked immune sorbent assay method. In this current study, as expected, patients with diabetes mellitus had significantly higher (p< 0.001) fasting blood glucose (FBG), body mass index (BMI), and glycated hemoglobin (HbA1c) levels as compared to the age-matched controls group. In addition, a significantly higher increase in the average level of urea, creatinine, and cystatin-c while significant higher decreases in vitamin D concentration compared to the patients group with the control group were found. A significant negative correlation was found between 25(OH) D and urea levels.
On the other hand, a significant positive correlation was observed between the 25(OH) D level and HbA1c, FBG, cystatin-c and creatinine. From the results of this work, vitamin D could be a valuable predictor of nephropathy in males with diabetes mellitus. Likewise, further work is required to suggest that vitamin D may be prone to nephropathy in all patients with diabetes mellitus by estimating cystatin C as a clinical risk for kidney function.
Keywords: Nephropathy, cystatin C, vitamin D.
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference20 articles.
1. 1. Umanath K, Lewis JB. Update on Diabetic Nephropathy: Core Curriculum 2018. Am J Kidney Dis. 2018; 71(6):884-895.
2. 2. Mrunalini KC, Mahmoud IM, Tahir H, Mohammed J, Aadil SI. Vitamin D and its analogs in type 2 diabetic nephropathy: a systematic review. Journal of Diabetes & Metabolic Disorders 2015; 14:58: 2-10.
3. 3. Zhang J, Liu J, Qin X. Advances in early biomarkers of diabetic nephropathy. Rev Assoc Med Bras. 2018; 64(1):85-92.
4. 4. Min Zhang, Tiejun Liu, Wenge Li, Weijun G., Xusheng Y., Jianing Xi. Efficacy of vitamin D3 in patients with diabetic nephropathy: an updated meta-analysis. Iran Red Crescent Med J. 2017; 19(12):e64275.
5. 5. Guan X, Yang H, Zhang W, Wang H, Liao L. Vitamin D receptor and its protective role in diabetic nephropathy. Chin Med J (Engl). 2014; 127(2):365.